Pneumococcal type 22F polysaccharide absorption improves the specificity of a pneumococcal-polysaccharide enzyme-linked immunosorbent assay

Clinical and Diagnostic Laboratory Immunology

Volumn 8, Issue 2, 2001, Pages 266-272

  Concepcion, N F ^a   Frasch, C E ^a  

^a CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; IMMUNOGLOBULIN G ANTIBODY; PNEUMOCOCCUS POLYSACCHARIDE;

ANTIBODY TITER; ARTICLE; CORRELATION FUNCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; PHAGOCYTOSIS; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; STATISTICAL ANALYSIS;

ADULT; ANTIBODY SPECIFICITY; BINDING, COMPETITIVE; CYTOTOXICITY TESTS, IMMUNOLOGIC; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; HUMANS; IMMUNOGLOBULIN G; PHAGOCYTOSIS; PNEUMOCOCCAL VACCINES; REPRODUCIBILITY OF RESULTS;

EID: 0035099207     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/CDLI.8.2.266-272.2001     Document Type: Article

References (23)

1. Differences in the avidity of antibodies evoked by four different pneumococcal conjugate vaccines in early childhood
2. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children
3. 5 pneumococcal strains
4. Evaluation of previously assigned antibody concentrations in pneumococcal polysaccharide reference serum 89SF by the method of cross-standardization
5. Characterization of the linkage between the type III capsular polysaccharide and the bacterial cell wall of group B Streptococcus
6. Specificity of human antibodies reactive with pneumococcal C polysaccharide
7. Which pneumococcal serogroups cause the most invasive disease: Implications for conjugate vaccine formulation and use, part I
8. Six newly recognized types of Streptococcus pneumoniae
9. Pneumococcal polysaccharide meningococcal outer membrane protein complex conjugate vaccine is immunogenic in infants and children
10. Serum antibodies to pneumococcal C polysaccharide in children: Response to acute pneumococcal otitis media or to vaccination
11. Functional differences in idiotypically defined IgG1 anti-polysaccharide antibodies elicited by vaccination with Haemophilus influenzae type B polysaccharide-protein conjugates
12. Natural and vaccine-related immunity to Strepococcus pneumoniae
13. Antibody to capsular polysaccharides of Streptococcus pneumoniae: Prevalence, persistence, and response to revaccination
14. Does naturally acquired IgG antibody to cell wall polysaccharide protect human subjects against pneumococcal infection?
15. Anti-C-carbohydrate antibodies after pneumococcal vaccination
16. 7 in United States infants
17. Standardization of an opsonophagocytic assay for the measurement of functional activity against Streptococcus pneumoniae using differentiated HL-60 cells
18. Are the enzyme immunoassays for antibodies to pneumococcal capsular polysaccharides type specific?
19. Covalent linkage between the capsular polysaccharide of Streptococcus pneumoniae revealed by immunochemical methods
20. Opsonization and antibodies to capsular and cell wall polysaccharides of Streptococcus pneumoniae
21. Assessment of responses to pneumococcal infection and vaccination using enzyme-linked immunoassay
22. The role of complement in the host's defense against Streptococcus pneumoniae
23. Pneumococcal capsular polysaccharide preparations may contain non-C-polysaccharide contaminants that are immunogenic